Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2019 Mar;28(3):591-601.
doi: 10.1158/1055-9965.EPI-18-0773. Epub 2018 Dec 6.

The ColoCare Study: A Paradigm of Transdisciplinary Science in Colorectal Cancer Outcomes

Cornelia M Ulrich #  1   2   3 , Biljana Gigic #  4 , Jürgen Böhm  5   2 , Jennifer Ose  5   2 , Richard Viskochil  5   2 , Martin Schneider  4 , Graham A Colditz #  6 , Jane C Figueiredo #  7 , William M Grady #  3   8   9 , Christopher I Li #  3 , David Shibata #  10 , Erin M Siegel #  11 , Adetunji T Toriola #  6 , Alexis Ulrich #  4
Affiliations
Observational Study

The ColoCare Study: A Paradigm of Transdisciplinary Science in Colorectal Cancer Outcomes

Cornelia M Ulrich et al. Cancer Epidemiol Biomarkers Prev. 2019 Mar.

Abstract

Background: Colorectal cancer is a leading cause of cancer death. Biomarkers to predict treatment outcomes are needed, as is evidence whether postdiagnosis diet and lifestyle can affect well-being and clinical outcomes. The international ColoCare Consortium aims to identify new biologic markers (e.g., metabolomic, transcriptomic, metagenomic, genetic, epigenetic, proteomic markers) that predict clinical outcomes, and to characterize associations between modifiable risk factors (e.g., diet, supplement use, physical activity) with short-term and long-term patient-reported and clinical outcomes among patients with colorectal cancer.Methods/Results: ColoCare is recruiting newly diagnosed patients with colorectal cancer across six sites in the United States and one site in Germany. As of April 2018, we have recruited >2,000 patients across all sites. Our projected enrollment is >4,000 multiethnic patients with colorectal cancer. The study includes uniformly collected, comprehensive sets of data and biospecimens at multiple time points up to 5 years after diagnosis. Treatment and clinical data are abstracted from medical records and centrally harmonized. Biospecimens are archived according to standardized procedures. Our initial studies demonstrated metabolic differences in adipose tissue types. We further reported on associations of biological factors (e.g., inflammation, DNA methylation, metabolomics) with lifestyle factors (e.g., adiposity, smoking, physical activity, dietary supplement use) or joint associations with clinical outcomes.

Conclusions: ColoCare is a consortium for the investigation of multilevel factors relevant to colorectal cancer survivorship.

Impact: The combination of a comprehensive set of biospecimens collected at multiple time points, jointly with detailed assessments of health behaviors and other prognostic factors, results in a unique resource that facilitates wide-ranging, innovative, and impactful research on colorectal cancer.

Trial registration: ClinicalTrials.gov NCT02328677.

PubMed Disclaimer

Conflict of interest statement

Disclosure of Potential Conflicts of Interest

The authors declare no conflict of interest.

Figures

Figure 1:
Figure 1:
ColoCare Study design. Not all components are collected at each time point and across all centers.
See this image and copyright information in PMC

References

    1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136(5):E359–86 doi 10.1002/ijc.29210. - DOI - PubMed
    1. Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin 2017;67(3):177–93 doi 10.3322/caac.21395. - DOI - PubMed
    1. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 2016;66(4):271–89 doi 10.3322/caac.21349. - DOI - PubMed
    1. Gigic B, Boeing H, Toth R, Bohm J, Habermann N, Scherer D, et al. Associations Between Dietary Patterns and Longitudinal Quality of Life Changes in Colorectal Cancer Patients: The ColoCare Study. Nutr Cancer 2017:1–10 doi 10.1080/01635581.2018.1397707. - DOI - PMC - PubMed
    1. Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, Buyse M, et al. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 2005;23(34):8664–70 doi 10.1200/JCO.2005.01.6071. - DOI - PubMed

Publication types

MeSH terms

Substances

Associated data